No. HT942526ORPCRA · Defense Health Agency Contracting Activity - DHACA
DoW Orthopaedic, Clinical Research Award
- Award range
- Not specified
- Expected awards
- ~5
- Application deadline
- Nov 18, 2026
- Posted
- Jun 17, 2026
- Last verified
- 2 days ago
At a glance
AI summaryThe FY26 Orthopaedic Clinical Research Award funds clinical research or clinical trials on orthopaedic-specific factors and interventions, with the goal of improving patient care and reducing the burden of orthopaedic injury. Applicants must address at least one listed focus area, and the program is aimed at benefits for Service Members, their families, Veterans, and the general public. U.S. Department of War organizations and other U.S. organizations, including foreign and domestic, for-profit and nonprofit, and public or private entities, may apply; eligible principal investigators can be at all career levels. Cost sharing is not required. The program expects about two awards at the Research Level 1 cap of $2.0 million each and about three awards at the Research Level 2 cap of $3.2 million each, with a maximum project period of 4 years. There are no geographic restrictions stated, but the notice says animal research is not allowed and that RL2 trials must begin within six months after the award date.
AI-generated summary — verify against the announcement
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Orthopaedic Research Program (ORP) Clinical Research Award (CRA) seeks clinical research that evaluates orthopaedic-specific factors and interventions. The ORP intends for research supported by this mechanism to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical care or policy. Applications must address how the proposed research will impact patient care and reduce the burden of orthopaedic injury and sequela. The ORP expects that research findings benefit Service Members, their families, Veterans and the general public. To meet the intent of the award mechanism, applications must specifically address at least one of the FY26 ORP CRA Focus Areas. Distinctive Features: · The CRA offers two research levels. Research Level 1 (RL1) supports clinical research in the following FY26 ORP focus areas: · Ligamentous Trauma · Osseointegration Outcomes · Return-to-Duty Strategies · Military Women’s Health Research Level 2 (RL2) supports clinical trials in the following FY26 ORP focus areas: · Ligamentous Trauma · Limb Stabilization and Protection · Return-to-Duty Strategies
Who can apply
- Unrestricted
Program history
USASpending.govAssistance listing 12.420 · Military Medical Research and Development
Real awards this federal program has made — the whole assistance listing (12.420), not just this notice.
| Fiscal year | Awards | Median award | Middle half |
|---|---|---|---|
| FY 2026 (so far) | 374 | $934,195 | $559,998 – $1,477,811 |
| FY 2025 | 967 | $796,174 | $416,995 – $1,480,602 |
| FY 2024 | 1,097 | — | — |
| FY 2023 | 1,115 | — | — |
| FY 2022 | 1,186 | — | — |
| FY 2021 | 1,023 | — | — |
Dollar figures are based on the 1,000 most recent awards we store, not all 5,762 — award counts are complete.
- THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER $19,100,256 · FY 2025
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. $18,696,738 · FY 2025
- UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE $10,606,583 · FY 2025
- SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH $10,500,000 · FY 2026
- UNIVERSITY OF VERMONT & STATE AGRICULTURAL COLLEGE $8,491,997 · FY 2025
Source: USASpending.gov · refreshed Aug 25, 2026